Partner Area
Logo Logo Logo Logo Logo
  • About Vacdiva
  • Work Packages
  • News
  • Vacdiva Activities
  • Our team
  • ASF
    • CURRENT STATUS
    • ASF news
    • DISEASE PROFILE
    • RISKS
    • WHAT DO WE HAVE?
    • WHAT IS NEEDED?
  • About Vacdiva
  • Work Packages
  • News
  • Vacdiva Activities
  • Our team
  • ASF
    • CURRENT STATUS
    • ASF news
    • DISEASE PROFILE
    • RISKS
    • WHAT DO WE HAVE?
    • WHAT IS NEEDED?

Archive

African swine fever ‘decimating’ Nigerian pigs 🇬🇧
11 junio, 2020
Don’t Take Your Eyes Off of African Swine Fever 🇬🇧
04 junio, 2020
African swine fever detected in China 🇬🇧
04 junio, 2020
Slow and steady progress for Latin American pig herd in 2020 🇬🇧
03 junio, 2020
Romania reports 263 African swine fever outbreaks, 11 ocurred in the last week 🇬🇧
02 junio, 2020
Retrospective spatial analysis for African swine fever in endemic areas to assess interactions between susceptible host populations 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

01 junio, 2020
China announces ban on pig imports from India 🇬🇧
28 mayo, 2020
Over 15,000 pigs dead due to African swine fever in Assam: State minister 🇬🇧
27 mayo, 2020
Environment ‘Unstoppable’: African swine fever deaths to eclipse record 2019 toll 🇬🇧
27 mayo, 2020
ASF Europe: more cases in wild boar population in 2020 🇬🇧
20 mayo, 2020
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34

VACDIVA is an Horizon 2020 European Project born with the aim of developing an effective vaccine against African Swine Fever.

Contact

info@vacdiva.eu

Copyright 2019 VACDIVA. All rights reserved
HORIZCIENCE project management
Legal notice | Cookies policy | Privacy policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy